» Articles » PMID: 36705390

A 20-year Trend of Prevalence and Susceptibility to Trimethoprim/sulfamethoxazole of Stenotrophomonas Maltophilia in a Single Secondary Care Hospital in Korea

Overview
Specialty General Medicine
Date 2023 Jan 27
PMID 36705390
Authors
Affiliations
Soon will be listed here.
Abstract

Stenotrophomonas maltophilia is a Gram-negative opportunistic pathogen that can cause serious infection. We aimed to analyze the prevalence and susceptibility rates to trimethoprim/sulfamethoxazole of S. maltophilia. We conducted a retrospective study of S. maltophilia isolates from a university hospital from 2001 to 2020. Clinical information, the numbers of isolates and susceptibility rates were analyzed by year. Susceptibility rates and changes in respiratory and non-respiratory samples were compared. 1805 S. maltophilia isolates were identified, of which 81.4% (1469/1805) were from respiratory samples. There was a male predominance and 52% of the isolates were from general wards. The average susceptibility rate was 87.7% and there was no significant annual trend (P = .519). The susceptibility rate was 88.7% in respiratory samples and 84.1% in non-respiratory samples (P = .018). Susceptibility analyses using clinical data over long periods can guide the choice of antimicrobials especially for pathogen whose treatment options are limited.

Citing Articles

Persistence of in Patients with Bacteremia: Incidence, Clinical and Microbiologic Characters, and Outcomes.

Kim S, Ji S, Cho D, Lee A, Jeong H, Kim M Microorganisms. 2025; 12(12.

PMID: 39770680 PMC: 11727890. DOI: 10.3390/microorganisms12122477.


Clinical characteristics and genome epidemiology of Stenotrophomonas maltophilia in Japan.

Hase R, Sakurai A, Suzuki M, Itoh N, Hayakawa K, Uemura K J Antimicrob Chemother. 2024; 79(8):1843-1855.

PMID: 38842502 PMC: 11290880. DOI: 10.1093/jac/dkae168.


Global mapping of antibiotic resistance rates among clinical isolates of Stenotrophomonas maltophilia: a systematic review and meta-analysis.

Bostanghadiri N, Sholeh M, Navidifar T, Dadgar-Zankbar L, Elahi Z, van Belkum A Ann Clin Microbiol Antimicrob. 2024; 23(1):26.

PMID: 38504262 PMC: 10953290. DOI: 10.1186/s12941-024-00685-4.